The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes
Open accessAbstract
OBJECTIVE— The aim of the study was to determine whether the loss of fasting and postprandial glycemic control occurs in parallel or sequentially in the evolution of type 2 diabetes. RESEARCH DESIGN AND METHODS— In 130 type 2 diabetic patients, 24-h glucose profiles were obtained using a continuous glucose monitoring system. The individuals with type 2 diabetes were divided into five groups according to A1C levels: 1 (<6.5%, n = 30), 2 (6.5–6.9%, n = 17), 3 (7–7.9%, n = 32), 4 (8–8.9%, n = 25), and 5 (≥9%, n = 26). The glucose profiles between the groups were compared. The overall glucose concentrations for the diurnal, nocturnal, and morning periods, which represent the postprandial, fasting, and the dawn phenomenon states, respectively, were also compared. RESULTS— Glucose concentrations increased steadily from group 1 to 5 in a stepwise manner. The initial differences in mean glucose concentrations reaching statistical significance occurred 1) between groups 1 and 2 (6.4 vs. 7.7 mmol/l, P = 0.0004) for daytime postprandial periods, followed by differences; 2) between groups 2 and 3 (7.5 vs. 9.3 mmol/l, P = 0.0003) for the morning periods (dawn phenomenon); and finally 3) between groups 3 and 4 (6.3 vs. 8.4 mmol/l, P < 0.0001) for nocturnal fasting periods. CONCLUSIONS— The deterioration of glucose homeostasis in individuals with type 2 diabetes progressed from postprandial to fasting hyperglycemia following a three-step process. The first step related to the three diurnal postmeal periods considered as a whole, the second step occurred during the morning period, and the third and final step corresponded to sustained hyperglycemia over the nocturnal fasting periods. Such a description of the key stages in the evolution of type 2 diabetes may be of interest for implementing antidiabetes treatment.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A 2-hour PPG <8.0 mmol/L correlates best with an A1C <7.0%.
“Another study using continuous glucose monitoring (CGM) demonstrated that a 2-hour PPG <8.0 mmol/L correlates best with an A1C <7.0% (40).”
From Targets for Glycemic Control (2018) · cites this paper as [40]
The Comparison of daytime postprandial periods section reports CGM-derived mean postprandial glucose of 7.7 mmol/L in the group with A1C of 6.5–6.9%, supporting a relationship between postprandial glucose and A1C. It does not establish that a glucose value measured two hours after a meal below 8.0 mmol/L correlates best with A1C below 7.0%. Page numbers are unavailable in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measuredIf an A1C target ≤7.0% cannot be achieved with a FPG target of 4.0-7.0 mmol/L and PPG target of 5.0-10.0 mmol/L, further FPG lowering to 4.0 to 5.5 mmol/L and/or PPG lowering to 5.0-8.0 mmol/L may be considered, but must be balanced against the risk of hypoglycemia.
“If an A1C target ≤7.0%cannot be achieved with a FPG target of 4.0-7.0mmol/L and PPG target of 5.0-10.0mmol/L, further FPG lowering to 4.0 to 5.5 mmol/L and/or PPG lowering to 5.0-8.0 mmol/L may be considered, but must be balanced against the risk of hypoglycemia [Grade D, Level 4 (38) for FPG target for type 2 diabetes; Grade D, Consensus for FPG target for type 1 diabetes; Grade D, Level 4 (38,40”
From Targets for Glycemic Control (2018) · cites this paper as [40]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredPostprandial hyperglycemia begins prior to type 2 diabetes occurring.
“Firstly, postprandial hyperglycemia has been shown to begin prior to type 2 diabetes occurring [3–5]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · see citing works
Predicting basal metabolic rate, new standards and review of previous work.
Wn, S. (1985) · PubMed · Cited by 2,911 · see citing works
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166 · see citing works
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940 · see citing works
Standards of Medical Care in Diabetes–2006
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s4 · Cited by 1,884 · see citing works
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479 · see citing works
Monnier, L., Lapinski, H., & Colette, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.881 · Cited by 1,461 · see citing works
Self-citationSacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360 · see citing works
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064 · see citing works
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 725 · see citing works
(1997) · Diabetes reviews · Cited by 671 · see citing works
Initiating Insulin Therapy in Type 2 Diabetes
Raskin, P., Allen, E., Hollander, P., Lewin, A., Gabbay, R. A., Hu, P., Bode, B., Garber, A., & for the INITIATE Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.2.260 · Cited by 560 · see citing works
Incretins, insulin secretion and Type 2 diabetes mellitus
Vilsbøll, T., & Holst, J. J. (2004) · Diabetologia · doi:10.1007/s00125-004-1342-6 · Cited by 444 · see citing works
Insulin glargine or NPH combined with metformin in type 2 diabetes: The LANMET study
Yki-Järvinen, H., Kauppinen-Mäkelin, R., Tiikkainen, M., Vähätalo, M., Virtamo, H., Nikkilä, K., Tulokas, T., Hulme, S., Hardy, K., McNulty, S., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0132-0 · Cited by 434 · see citing works
The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus
Pratley, R. E., & Weyer, C. (2001) · Diabetologia · doi:10.1007/s001250100580 · Cited by 419 · see citing works
Janka, H. U., Plewe, G., Riddle, M. C., Kliebe-Frisch, C., Schweitzer, M. A., & Yki-Järvinen, H. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.254 · Cited by 414 · see citing works
Wolever, T. M. S. (2015) · World review of nutrition and dietetics · doi:10.1159/000417536 · Cited by 326 · see citing works
Carbohydrate Metabolism in Non-Insulin-Dependent Diabetes Mellitus
Dinneen, S., Gerich, J., & Rizza, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271007 · Cited by 279 · see citing works
Standards of Medical Care for Patients With Diabetes Mellitus
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s33 · Cited by 262 · see citing works
Bolli, G. B., & Gerich, J. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403223101203 · Cited by 235 · see citing works
Boden, G., Chen, X., & Urbain, J. L. (1996) · Diabetes · doi:10.2337/diab.45.8.1044 · Cited by 228 · see citing works
Shetty, P. S., Henry, C. J., Black, A., & Prentice, A. M. (1996) · PubMed · Cited by 159 · see citing works
Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., & Parrott, M. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.4.750 · Cited by 145 · see citing works
Woerle, H. J., Pimenta, W. P., Meyer, C., Gosmanov, N. R., Szoke, E., Szombathy, T., Mitrakou, A., & Gerich, J. E. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.15.1627 · Cited by 130 · see citing works
Treating Postprandial Hyperglycemia Does Not Appear to Delay Progression of Early Type 2 Diabetes
Kirkman, M. S., Shankar, R. R., Shankar, S. S., Shen, C., Brizendine, E. J., Baron, A., & McGill, J. B. (2006) · Diabetes Care · doi:10.2337/dc06-0061 · Cited by 49 · see citing works
Boden, G., Chen, X., & Urbain, J. L. (1996) · Diabetes · doi:10.2337/diabetes.45.8.1044 · Cited by 43 · see citing works
Evaluation of the Menarini–Arkray HA 8140 hemoglobin A1c analyzer
John, W. G., Braconnier, F., Miedema, K., Aulesa, C., & Piras, G. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.6.968 · Cited by 42 · see citing works
Sinclair, E. M., & Drucker, D. J. (2005) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000155379.11926.e2 · Cited by 39 · see citing works
Terreni, A., Paleari, R., Caldini, A. L., Ognibene, A., Mosca, A., & Messeri, G. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00116-4 · Cited by 15 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [18]18. Zar JH: Testing for goodness of fit. In Bio- statistical Analysis. 4th ed. Upper Saddle River, NJ, Prentice Hall, 1999, p. 461- 485
Cited by
Sorted by citations
Hormonal regulation of hepatic glucose production in health and disease
Lin, H. V., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.003 · Cited by 429 · see citing works
Meier, J. J., Rosenstock, J., Hincelin-Méry, A., Roy-Duval, C., Delfolie, A., Coester, H.-V., Menge, B. A., Forst, T., & Kapitza, C. (2015) · Diabetes Care · doi:10.2337/dc14-1984 · Cited by 262 · see citing works
Riddle, M., Umpierrez, G., DiGenio, A., Zhou, R., & Rosenstock, J. (2011) · Diabetes Care · doi:10.2337/dc11-0632 · Cited by 219 · see citing works
Imran, S. A., Agarwal, G., Bajaj, H. S., & Ross, S. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.030 · Cited by 113 · see citing works
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
Ajjan, R. A., Battelino, T., Cos, X., Del Prato, S., Philips, J.-C., Meyer, L., Seufert, J., & Seidu, S. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00973-1 · Cited by 117 · see citing works
Update on biomarkers of glycemic control
Krhač, M., & Lovrenčić, M. V. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i1.1 · Cited by 93 · see citing works
Beejmohun, V., Peytavy-Izard, M., Mignon, C., Muscente-Paque, D., Deplanque, X., Ripoll, C., & Chapal, N. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-351 · Cited by 97 · see citing works
Monnier, L., Colette, C., & Owens, D. R. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.962 · Cited by 89 · see citing works
Self-citationJarvis, P. R. E., Cardin, J. L., Nisevich-Bede, P. M., & McCarter, J. P. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155640 · Cited by 86 · see citing works
Monnier, L., & Colette, C. (2009) · Diabetes Care · doi:10.2337/dc09-s310 · Cited by 82 · see citing works
Self-citationWhite, A. M., & Johnston, C. S. (2007) · Diabetes Care · doi:10.2337/dc07-1062 · Cited by 58 · see citing works
González-Ortiz, M., Guerrero-Romero, J. F., Violante-Ortiz, R., Wacher-Rodarte, N., Martínez-Abundis, E., Aguilar-Salinas, C., Islas-Andrade, S., Arechavaleta-Granell, R., González-Canudas, J., Rodríguez-Morán, M., et al. (2009) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.09.002 · Cited by 50 · see citing works
Onishi, Y., Niemoeller, E., Ikeda, Y., Takagi, H., Yabe, D., & Seino, Y. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12275 · Cited by 13 · see citing works
Watada, H., Imori, M., Li, P., & Iwamoto, N. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0020 · Cited by 2 · see citing works
- Authors
- Monnier, L., Colette, C., Dunseath, G. J., & Owens, D. R.
- Affiliations
- Hôpital Lapeyronie (FR)
- Laboratory of Human Nutrition and Atherogenesis, University Institute of Clinical Research, Montpellier, France
- University Hospital Llandough (GB)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-02-01
- Volume
- 30
- Issue
- 2
- Pages
- 263-269
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2127454519
- Cited by
- 490
- References
- 31
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 17 · 2023: 16 · 2022: 17 · 2021: 20 · 2020: 14 · 2019: 22 · 2018: 27 · 2017: 33 · 2016: 31 · 2015: 24 · 2014: 40 · 2013: 35 · 2012: 27
- FWCI
- 28.26
- Type
- journal article
- Language
- en
- Open access
- green
- orca.cardiff.ac.uk
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, glycemic control, postprandial hyperglycemia, fasting hyperglycemia, dawn phenomenon, HbA1c, disease progression, glucose homeostasis, continuous glucose monitoring
- MeSH terms
- Blood Glucose, Blood Pressure, Energy Intake, Diabetes Mellitus, Type 2, Eating, Fasting, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Disease Progression, Monitoring, Ambulatory, Postprandial Period, Glycemic Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review